A New Jersey pharmaceutical company has voluntarily recalled thousands of bottles of a combination blood pressure medication after testing suggested possible cross-contamination with another drug, according to the Food and Drug Administration (FDA).
The recall involves more than 11,100 bottles of bisoprolol fumarate and hydrochlorothiazide tablets sold under the brand name Ziac. During routine testing of reserve samples, ezetimibe — a medication used to help lower cholesterol — was detected, FDA officials reported.
Regulators classified the action as a Class III recall, indicating that use or exposure to the affected product is not likely to result in adverse health consequences.
Glenmark Pharmaceuticals Inc., based in Elmwood Park, N.J., is recalling 2.5 milligram and 6.25 milligram tablet strengths. The FDA says the affected packages include:
- 30-count bottles, NDC 68462-878-30
- 100-count bottles, NDC 68462-878-01
- 500-count bottles, NDC 68462-878-05
The impacted lots carried expiration dates ranging from November 2025 through May 2026.
